Risk of postnatal exposure to Sarcocystis neurona and Neospora hughesi in horses

Am J Vet Res. 2004 Aug;65(8):1047-52. doi: 10.2460/ajvr.2004.65.1047.

Abstract

Objective: To estimate risk of exposure and age at first exposure to Sarcocystis neurona and Neospora hughesi and time to maternal antibody decay in foals.

Animals: 484 Thoroughbred and Warmblood foals from 4 farms in California.

Procedure: Serum was collected before and after colostrum ingestion and at 3-month intervals thereafter. Samples were tested by use of the indirect fluorescent antibody test; cutoff titers were > or = 40 and > or = 160 for S neurona and N hughesi, respectively.

Results: Risk of exposure to S neurona and N hughesi during the study were 8.2% and 3.1%, respectively. Annual rate of exposure was 3.1% for S neurona and 1.7% for N hughesi. There was a significant difference in the risk of exposure to S neurona among farms but not in the risk of exposure to N hughesi. Median age at first exposure was 1.2 years for S neurona and 0.8 years for N hughesi. Highest prevalence of antibodies against S neurona and N hughesi was 6% and 2.1 %, respectively, at a mean age of 1.7 and 1.4 years, respectively. Median time to maternal antibody decay was 96 days for S neurona and 91 days for N hughesi. There were no clinical cases of equine protozoal myeloenchaphlitis (EPM).

Conclusions and clinical relevance: Exposure to S neurona and N hughesi was low in foals between birth and 2.5 years of age. Maternally acquired antibodies may cause false-positive results for 3 or 4 months after birth, and EPM was a rare clinical disease in horses < or = 2.5 years of age.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Animals
  • Antibodies, Protozoan / blood*
  • Antibodies, Protozoan / immunology
  • California
  • Coccidiosis / immunology
  • Coccidiosis / veterinary*
  • Fluorescent Antibody Technique, Indirect
  • Horse Diseases / immunology
  • Horse Diseases / parasitology*
  • Horses
  • Immunity, Maternally-Acquired / immunology
  • Neospora*
  • Risk Assessment
  • Sarcocystis*

Substances

  • Antibodies, Protozoan